The core problem SGE addresses is combinatorial explosion. A synthetic metabolic pathway is not simply a collection of genes; it is a carefully tuned arrangement of coding sequences, promoters, expression levels and subcellular addresses. Each design variable multiplies the number of possible configurations, and in mammalian cells the search space quickly becomes unmanageable. Microbial engineers sidestep this with rapid design-build-test cycles: Escherichia coli doubles every twenty minutes and budding yeast every ninety, so iterative refinement is cheap. Mammalian cells, with doubling times exceeding twenty hours, make such iteration painfully slow. Worse, delivering large DNA constructs into mammalian cells is exponentially less efficient as construct size grows, so brute-force screening of complete multigene pathways has been impractical beyond roughly ten kilobases.

SGE flips the logic of construct design. Instead of building and delivering one large pathway at a time, the researchers assembled a pooled library of small, individually barcoded transcription units, each consisting of a coding sequence paired with a promoter and, in some cases, an organellar localization signal. Because small DNA fragments are vastly easier to synthesize, assemble and package into lentivirus, the library could be delivered at high multiplicity of infection, so each cell received a random assortment of components. Every infected cell thereby became a unique pathway variant, exploring different gene content, stoichiometry and localization simultaneously. After selection for a desired phenotype, sequencing the barcodes from surviving cells reveals which combinations of parts conferred the function.

As a test case, the team targeted branched-chain amino acid biosynthesis. Mammals lost the ability to synthesize nine essential amino acids deep in evolutionary history and must obtain them from food, making amino acid auxotrophy a stringent and convenient selection scheme: cells simply die unless they acquire the pathway. In previous work, the group had shown that four E. coli genes, ilvN, ilvB, ilvC and ilvD, could confer valine prototrophy on CHO cells, but growth remained slow at 3.8 days per doubling, and the same genes failed to enable isoleucine biosynthesis despite overlapping enzymatic steps. For the SGE library, they expanded the toolkit to ten coding sequences, adding ilvA to supply the isoleucine-specific substrate 2-oxobutanoate, two feedback-resistant ilvA variants, and the isozymes ilvG and ilvM, which form an acetohydroxy acid synthase II complex with a strong preference for the isoleucine substrate and insensitivity to end-product inhibition.

Each coding sequence was paired with either the strong EF1a or the medium-strength PGK promoter, with or without a mitochondrial targeting sequence, yielding a forty-member transcription unit library. The researchers infected 2.42 million CHO cells at a multiplicity of infection of 8.8 and used Monte Carlo simulations to confirm that the resulting diversity was sufficient to capture all plausible four- and five-component pathway combinations. After fifteen days of selection in low-valine medium, clonal outgrowths appeared only in the experimental population. All sixteen isolated clones proved valine prototrophic, and the best performers doubled in 1.1 days in valine-free medium, roughly 83 percent of their growth rate in complete medium and a dramatic improvement over the rationally designed pathway of the earlier study.

Barcode sequencing revealed a consistent architectural principle. In strongly prototrophic clones, the winning configuration placed mitochondrially targeted ilvN, ilvB, ilvC and ilvD under PGK promoter control, a solution rational design had never identified. Mitochondrial colocalization of all four genes was enriched forty-eight-fold relative to random expectation, and no clone showed all four enzymes in the cytoplasm. The researchers reconstructed this SGE-informed pathway on a single DNA construct using yeast homologous recombination and Flp-In integration, and it drove valine-free growth at 1.25 days per doubling, substantially outperforming the original design. Isotope tracing with carbon-13-labeled glucose and pyruvate confirmed that the engineered cells were genuinely synthesizing valine endogenously at rates comparable to the native mammalian synthesis of the nonessential amino acid alanine.

The isoleucine results were even more striking. Rational design had failed to produce isoleucine-prototrophic CHO cells, but SGE succeeded. Among forty-six clones selected on low-isoleucine medium, nineteen showed improved prototrophy, and the strongest clone grew in isoleucine-free medium at 1.69 days per doubling. Every strongly prototrophic clone carried barcodes for six genes: ilvB, ilvC, ilvD, ilvG, ilvM and the partially feedback-resistant ilvA(L481F). Again, mitochondrial localization dominated, with the six-gene mitochondrial configuration enriched 217-fold over expectation and the fully cytoplasmic alternative never observed. Mass spectrometry detected the expected carbon-13 isotopologs of isoleucine, confirming endogenous synthesis of a metabolic function last present in the mammalian lineage over 500 million years ago. The integrated constructs spanned roughly 23 to 52 kilobases of synthetic DNA, far beyond what conventional screening approaches can deliver and test.

To demonstrate generality, the team deployed the same lentiviral library in Jurkat cells, a human T lymphocyte line that grows in suspension. Three million infected cells at a lower multiplicity of 3.4 yielded valine-prototrophic clones after selection, with 71 percent of 119 isolated clones passing the prototrophy threshold and the best performers doubling in under about two days without valine. The pathway solution mirrored the CHO result: mitochondrially localized ilvN, ilvB, ilvC and ilvD under PGK control, enriched 283-fold over random expectation. Isoleucine prototrophy, predicted by simulation to be vanishingly rare at the achieved library coverage, did not emerge, illustrating how Monte Carlo modeling of transcription unit distributions and multiplicity can guide experimental design and set realistic expectations before a screen begins.

The datasets generated by SGE also proved rich enough for machine learning. The researchers trained a random forest classifier on the barcode-derived transcription unit composition of each Jurkat clone, using it to predict whether a clone would be prototrophic or auxotrophic. With stratified fourfold cross-validation, the model achieved a mean accuracy of 0.942 and an area under the ROC curve of 0.993, and its top predictive features were precisely the four mitochondrially localized, PGK-driven genes that manual analysis had identified as the optimal pathway. This demonstration points toward a future in which large-scale synthetic perturbation data, rather than observational datasets shaped by natural evolution, train predictive models capable of generative metabolic design in mammalian systems.

The authors acknowledge limitations, including the current reliance on selectable phenotypes, biases introduced during lentiviral packaging that underrepresented certain promoters and coding sequences, and the fact that barcode sequencing reveals integration but not expression, which RNA sequencing must supplement. Even so, the implications are broad. Cells engineered for amino acid prototrophy could reduce the cost and complexity of media for biomanufacturing, cultivated meat and viral vector production, while immune cells metabolically augmented to withstand the nutrient-poor, acidic and inflammatory tumor microenvironment could improve cell therapies for solid cancers. The team anticipates extending SGE to larger libraries, additional essential nutrients, vitamins and growth factors, stress tolerance traits, and integration with CRISPR-based host factor modulation, establishing a scalable framework for pathway-scale engineering of increasingly complex biosynthetic traits in mammalian cells.

Subject of Research: Highly multiplexed mammalian metabolic engineering using barcoded shotgun genetic engineering to screen millions of synthetic amino acid biosynthesis pathways

Article Title: Highly multiplexed mammalian metabolic engineering with a shotgun approach

Article References: Trolle, J., Sessa, S., Wudzinska, A., Grivainis, M., Rincones, K., Rodrick, T., Jones, D. R., Fenyö, D., Pinglay, S., & Boeke, J. D. (2026). Highly multiplexed mammalian metabolic engineering with a shotgun approach. Nature Biotechnology. https://doi.org/10.1038/s41587-026-03318-7

Image Credits: AI Generated

DOI: 10.1038/s41587-026-03318-7

Keywords: shotgun genetic engineering, metabolic engineering, synthetic biology, mammalian cells, CHO cells, Jurkat cells, amino acid biosynthesis, valine, isoleucine, mitochondrial localization, machine learning, high-throughput screening

The researchers set out to resolve a puzzle that has shadowed nutrition science for years. Protein is indispensable, fueling muscle growth, immune regulation, and bone development, yet large epidemiological studies have linked very high protein intake to elevated all-cause mortality and to age-related conditions such as chronic kidney disease and type 2 diabetes. Meanwhile, dozens of experiments in organisms from yeast to mice have shown that restricting protein extends life. What has been missing is a dynamic, mechanistic account of how excess protein actually promotes aging across the lifespan, rather than a snapshot taken at a single moment in time.

To fill that gap, the team turned to Drosophila melanogaster, the fruit fly, a classic aging model whose short life makes lifelong observation practical. They fed flies a series of six diets with identical total calories but protein energy supplies ranging from 5 to 30 percent, carefully adjusting glucose so that only the protein-to-carbohydrate ratio changed. The result was a striking inverted U-shaped curve. Flies on the 10 percent protein diet lived longest, with a median lifespan of 75 days. As protein climbed, lifespan fell in a dose-dependent manner, dropping to just 54 days at 30 percent protein. Even the extreme 5 percent diet shortened life, confirming that both too little and too much protein are harmful. Food intake measurements ruled out the possibility that flies on high-protein diets were simply eating more calories, and climbing tests showed the effect was not an artifact of general frailty at the start of the intervention.

With the lifespan effect established, the researchers deployed a formidable multi-omics arsenal. They sequenced the transcriptomes of flies at day 18, representing early life, and day 48, representing middle-to-late life, across all five protein levels, and complemented this with quantitative proteomics and amino acid metabolic profiling. By correlating the expression of every gene with lifespan grades across the dietary spectrum, they narrowed thousands of candidates down to a shortlist of genes that responded consistently to high protein at both life stages. Pathway analysis kept pointing to one metabolic hub: the glycine, serine, and threonine metabolism pathway, which was strongly and persistently activated by high-protein diets at both the RNA and protein levels, and whose activity scores correlated negatively with lifespan with Spearman coefficients as high as minus 0.97.

Within that pathway, a protein interaction network analysis flagged one gene as the top-ranked hub: CG6415, the fly homolog of the human AMT gene. Its expression rose steadily as dietary protein increased and lifespan fell, and it was also among a set of 150 genes whose expression changed in the same direction during natural aging, suggesting that the diet essentially hijacks a program the animal already runs as it grows old. To test causality, the team generated flies in which CG6415 was either deleted entirely or overexpressed throughout the body. The results were decisive. Knocking out CG6415 extended the median lifespan of flies on the 30 percent protein diet by 15.7 percent and restored the activity of antioxidant enzymes such as superoxide dismutase and catalase, which the high-protein diet had suppressed. Conversely, forcing CG6415 expression on a normal 10 percent protein diet shortened median lifespan by 22 percent, mimicking the effect of a high-protein diet without any change in nutrition. Combining overexpression with a high-protein diet produced the worst survival of all, a clear additive interaction confirmed statistically by two-way analysis of variance.

The mechanism, the omics data indicated, centered on oxidative phosphorylation, the mitochondrial process that converts nutrients into ATP. High-protein diets suppressed the oxidative phosphorylation pathway, activated senescence-related signaling through the p53 pathway, and dampened electron transport and ion transport, all changes that CG6415 knockout reversed. ATP levels told the same story: they fell significantly in high-protein-fed flies and were partially restored by deleting CG6415. Because oxidative phosphorylation is the core function of mitochondria, the team reasoned that CG6415 must be acting on mitochondrial homeostasis itself.

To test that idea in a mammalian context, the researchers moved to human embryonic kidney 293T cells, a validated model for mitochondrial and aging studies, and manipulated AMT, the human counterpart of CG6415. Overexpressing AMT reduced the activities of mitochondrial respiratory chain complexes I, II, III, and V, lowered cellular ATP, collapsed the mitochondrial membrane potential, and flooded the cells with reactive oxygen species, including mitochondria-specific superoxide detected with the MitoSOX probe. Senescence markers followed: senescence-associated beta-galactosidase staining increased, inflammatory genes such as TNF-alpha, IL-1 beta, and IL-6 were upregulated, and the canonical p53-p21 senescence pathway switched on at both the mRNA and protein levels. In the reverse experiment, silencing AMT with siRNA in cells stressed by hydrogen peroxide restored complex V activity, ATP production, and membrane potential, reduced ROS, and blunted the p53-p21 response, demonstrating that the AMT-ROS-p53-p21 axis is a genuine conduit from mitochondrial dysfunction to cellular senescence.

The final question was which component of dietary protein drives the effect. Proteins are built from twenty amino acids, so the team profiled the amino acid pools of high-protein-fed flies and then supplemented each amino acid individually onto the baseline 10 percent protein diet. Three of them, isoleucine, valine, and phenylalanine, shortened lifespan significantly, by roughly five to six days, while several others, including threonine, methionine, and glycine, actually extended it. Molecular docking showed that all three lifespan-shortening amino acids can bind the CG6415 protein, but only isoleucine reliably upregulated the gene in the fly thorax and abdomen and impaired both oxidative and heat stress resistance. Crucially, CG6415 knockout rescued the lifespan reduction caused by isoleucine supplementation, extending median lifespan by nine days, and lowering dietary isoleucine within a high-protein diet extended lifespan in control flies but not in CG6415-overexpressing ones. Isoleucine also reproduced the dose-response relationship of the full high-protein diet, with lifespan shortening progressively as supplementation increased. Together, these experiments position isoleucine as the key amino acid through which high-protein diets activate CG6415 and promote aging, a finding that resonates with earlier mouse studies showing that dietary isoleucine restriction extends healthspan and lifespan.

The authors are careful about the limits of their work. The study relied primarily on flies, with human cells used only for mechanistic verification, and organ-specific studies in mammals remain to be done. Individual amino acid supplementation only partially reproduced the high-protein effect, hinting that protein’s impact on aging emerges from the combined action of multiple amino acids rather than any single one. The researchers also focused on pathways uniformly regulated across two life stages, leaving stage-specific effects for future exploration. Still, the implications are hard to ignore. At a time when protein supplements are marketed aggressively to adolescents, fitness enthusiasts, and older adults alike, the study offers a cautionary counterweight: sustained excessive protein intake, particularly of isoleucine-rich foods, may quietly erode mitochondrial function and accelerate the very aging process that health-conscious consumers are trying to delay. The identification of CG6415/AMT as a druggable node in this pathway, and of isoleucine as its dietary trigger, opens a concrete path toward precision nutrition, in which protein quality and amino acid composition, not just quantity, become the targets of anti-aging dietary design.

Subject of Research: Mechanism by which high-protein diets accelerate aging through CG6415/AMT gene activation and mitochondrial dysfunction

Article Title: High-protein diet promotes aging by activating the CG6415 / AMT gene and disrupting mitochondrial homeostasis

Article References: Xu, X., Zheng, W., Liu, Q., Li, Y., Yang, S., Zhou, R., Wang, Y., Qi, X., Zhang, C., Zhang, F., Wu, Y., Li, Y., & Li, Y. (2026). High-protein diet promotes aging by activating the CG6415/AMT gene and disrupting mitochondrial homeostasis. Journal of Advanced Research, 88, 995-1012. https://doi.org/10.1016/j.jare.2026.01.063

Image Credits: AI Generated

DOI: 10.1016/j.jare.2026.01.063

Keywords: high-protein diet, aging, lifespan, Drosophila melanogaster, CG6415, AMT gene, mitochondria, oxidative phosphorylation, isoleucine, reactive oxygen species, p53-p21 pathway, nutrition